HPN (Hepsin) Gene

Transmembrane serine protease involved in cell growth, coagulation, and cancer progression

Gene Information Card

Symbol HPN
Full Name Hepsin
Gene Type protein-coding
Chromosomal Location 19q13.11
NCBI Gene ID 3249 ncbi.nlm.nih.gov/gene/3249
Ensembl ID ENSG00000105707
UniProt ID P05981
OMIM ID 142440
HGNC ID 5155
Aliases TMPRSS1, HPN1

Description

HPN encodes hepsin, a type II transmembrane serine protease expressed primarily in the liver and prostate. Hepsin plays a role in cell growth, maintenance of cell morphology, and blood coagulation by activating factor VII. Overexpression is associated with prostate cancer progression and poor prognosis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Prostate cancer Overexpression of HPN leads to increased cell invasion and metastasis via activation of matriptase and other substrates. PMID: 11526490, PMID: 14660795
Hepatocellular carcinoma HPN upregulation correlates with tumor aggressiveness and poor survival. PMID: 16982746
Coagulation disorders Hepsin activates factor VII, contributing to the extrinsic coagulation pathway; dysregulation may affect hemostasis. PMID: 10578056

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 52.3 High
Prostate 38.1 High
Kidney 12.4 Medium
Lung 5.2 Low
Breast 2.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 45.6 Liver cancer cell line
LNCaP 32.8 Prostate cancer cell line
PC-3 28.4 Prostate cancer cell line
MCF7 3.1 Breast cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1250G>A (p.Arg417Gln) Missense <0.01% Reported in ClinVar as uncertain significance; may affect protease activity.
c.1129C>T (p.Arg377Trp) Missense <0.01% Likely benign; no functional data.
c.1465G>A (p.Glu489Lys) Missense <0.01% Uncertain significance; observed in cancer samples.
Mutation functional classification

Loss of Function (LOF)

No confirmed loss-of-function mutations reported in ClinVar or COSMIC for HPN.

Gain of Function (GOF)

Overexpression and amplification in prostate cancer suggest gain-of-function at expression level, but no specific activating mutations are documented.

Dominant Negative (DN)

No dominant-negative mutations reported.

Gene Ontology (GO)

• serine-type endopeptidase activity • proteolysis
• extracellular matrix disassembly • cell surface receptor signaling pathway
• blood coagulation

Pathways

Extrinsic coagulation pathway
Prostate cancer signaling

Protein Summary

Hepsin is a 417-amino acid type II transmembrane serine protease with a short cytoplasmic domain, a transmembrane domain, and an extracellular serine protease domain. It is synthesized as a zymogen and activated by cleavage. Hepsin is anchored to the plasma membrane and can be shed into the extracellular space. It activates pro-hepatocyte growth factor (pro-HGF) and pro-macrophage stimulating protein (pro-MSP), promoting cell scattering and invasion.

Related Products

Product name Cat.No. Species Gene ID
HPN Knockout HEK293 Cell Line EDJ-KQ4930 Human 3249 Details Get a Quote
RHPN2 Knockout HEK293 Cell Line EDJ-KQ10353 Human 85415 Details Get a Quote
RHPN2 Knockout A-549 Cell Line EDJ-KQ37668 Human 85415 Details Get a Quote
RHPN2 Knockout HCT 116 Cell Line EDJ-KQ37669 Human 85415 Details Get a Quote
RHPN2 Knockout HeLa Cell Line EDJ-KQ37670 Human 85415 Details Get a Quote
HPN Knockout HeLa Cell Line EDJ-KQ53566 Human 3249 Details Get a Quote
HPN Knockout A-549 Cell Line EDJ-KQ62033 Human 3249 Details Get a Quote
HPN Knockout HCT 116 Cell Line EDJ-KQ70515 Human 3249 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: